Get started Log in

VIVE — Vivesto AB Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
SEK79.82m
Enterprise Value
SEK56.31m
Revenue

Brief: Oasmia Presents Cantrixil Final Phase I Data At The 2021 AACR Annual Meeting
12/04/2021 06:03
Brief: Oasmia Wins Sole Rights To Record Patents In Its Own Name And Is Awarded Full Legal Costs
25/03/2021 06:37
Brief: Oasmia: European Patent Office To Grant Xmena Patent
24/03/2021 06:02
Brief: Oasmia And Karolinska Institutet To Collaborate
03/03/2021 06:05
Australia's Kazia Therapeutics gains on license deal with Swedish firm
02/03/2021 03:27
Brief: Oasmia Buys Global Development And Commercialization Rights For Cantrixil
01/03/2021 06:02
Brief: Oasmia Pharmaceutical Q3 Oper Loss Narrows To SEK 28.6 Mln
19/02/2021 07:19
Brief: Oasmia Secures IP Rights In Australia And Brazil
29/12/2020 06:02
Brief: Oasmia’s Partner Signs Licensing Deal For Commercialization Of Apealea in Europe
28/12/2020 06:03
Brief: Oasmia Q2 Operating Loss Widens To SEK 53.7 Mln
09/12/2020 07:05
Brief: Oasmia’s Partner Elevar Provides Update On Apealea Development Plans In Ovarian Cancer
03/12/2020 12:09
Brief: Oasmia Pharmaceutical Appoints Robert Maiorana As Acting CFO
27/11/2020 06:04
Brief: Oasmia Says Xmena Patent Approved In India And Soon In Australia
26/10/2020 06:04
Brief: The Disciplinary Committee Of Nasdaq Stockholm Orders Oasmia Pharmaceutical To Pay A Fine
14/10/2020 10:31
Brief: Oasmia Pharmaceutical Brings Action Against The Former Board Of Directors
25/09/2020 12:42
Brief: Oasmia Pharmaceutical Appoints Fredrik Järrsten As CFO
08/09/2020 06:38
Brief: Oasmia Pharmaceutical CFO Resigns
01/09/2020 06:44
Brief: Capital Conquest Buys 2.6 Million Shares In Oasmia Pharmaceutical
24/06/2020 14:11
Brief: Oasmia Pharmaceutical Signs Phase 1B Trial Agreement With SAKK
08/06/2020 06:04
Brief: Oasmia Pharmaceutical Enters Into Settlement Agreement
01/06/2020 08:34